Table: Brightpath Biotherapeutics -2024/25 parent forecast

BrightPath Biotherapeutics Co

24/03/2025 09:00

Mar 24 (Reuters) -
              Brightpath Biotherapeutics Co., Ltd.     
              PARENT- ONLY EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2025      Mar 31, 2025   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales            1 mln             0 mln      
  Operating      loss 1.11       loss 925 mln   
  Recurring      loss 1.11       loss 925 mln   
  Net            loss 1.11       loss 927 mln   
  EPS         loss 13.57 yen    loss 13.08 yen  
 
  NOTE - Brightpath Biotherapeutics Co., Ltd..    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T